MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Interest Expense 2011-2026 | EW
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 M | 68.9 M | 13.9 M | 4.8 M | 18.4 M | 15.8 M | 20.7 M | 29.9 M | 23.2 M | 19.2 M | 17.2 M | 17.2 M | 9.8 M | 4.4 M | 3.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 68.9 M | 3.1 M | 18.2 M |
Quarterly Interest Expense Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.7 M | -1.3 M | 2.6 M | - | 27.9 M | 2 M | 5.7 M | - | 6.6 M | 2.5 M | 1.6 M | - | -2 M | 4.3 M | -3.3 M | - | 1.4 M | 4.4 M | 5.5 M | - | 5.7 M | -300 K | 1.9 M | - | 4.6 M | 1.4 M | 1.8 M | - | 300 K | - | 3.1 M | - | 100 K | 1.4 M | 2.4 M | - | 2.1 M | 2.4 M | 2.4 M | - | -200 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.9 M | -3.3 M | 2.99 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M |  USA |
 |
Delcath Systems
DCTH
|
-70 K | $ 9.13 | -0.76 % | $ 327 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.38 | -1.78 % | $ 722 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
Inogen
INGN
|
2.44 M | $ 6.5 | 1.25 % | $ 173 M | USA |
 |
IRadimed Corporation
IRMD
|
164 K | $ 98.74 | -2.99 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.35 | 0.74 % | $ 384 M | USA |
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | USA |
 |
LENSAR
LNSR
|
660 K | $ 5.52 | -1.08 % | $ 63.6 M | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 36.64 | -1.19 % | $ 1.14 B | USA |
 |
Medtronic PLC
MDT
|
402 M | $ 87.67 | -0.24 % | $ 113 B | USA |
 |
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
78 K | $ 24.45 | -0.85 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
8.11 M | $ 11.79 | -1.17 % | $ 467 M |  Curacao |
 |
Outset Medical
OM
|
14 M | $ 3.52 | -0.28 % | $ 53.5 K | USA |
 |
Aethlon Medical
AEMD
|
10.1 K | $ 2.27 | -2.16 % | $ 3.54 M | USA |
 |
PAVmed
PAVM
|
-10.5 M | $ 8.94 | -3.87 % | $ 64.7 M | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
664 K | $ 63.65 | 0.55 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
200 K | $ 1.73 | -2.26 % | $ 111 M |  Israel |
 |
Insulet Corporation
PODD
|
14.3 M | $ 218.11 | 0.98 % | $ 15.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.41 | 0.18 % | $ 1.54 B | USA |
 |
Quanterix Corporation
QTRX
|
157 K | $ 3.9 | -1.52 % | $ 166 M | USA |
 |
Penumbra
PEN
|
893 K | $ 336.42 | 0.04 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
-558 K | $ 3.94 | -3.9 % | $ 582 M | USA |
 |
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
99 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-668 K | $ 0.68 | -2.2 % | $ 28.5 M | USA |
 |
Inspire Medical Systems
INSP
|
-2.66 M | $ 50.45 | -1.87 % | $ 1.48 B | USA |